Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 14 Sept 2026 for Biomarin Pharmaceutical INC. Read the official filing
Filing timeline
BuySaleRobert M. Plenge
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Robert M. Plenge: trading record in brief
Robert M. Plenge is a declared insider at 2 companies; the most frequent names are Bristol Myers Squibb Co and Biomarin Pharmaceutical Inc. In total, 6 filings cover trades dated from 3 August 2023 to 10 September 2026.
Sales make up the whole of the open-market record (1 sale, €41k). The rest of the record consists of 1 share grant and 4 option exercises.
The newest entry dates from 14 September 2026: a share grant, in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert M. Plenge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,140 shares0Common StockSEC:0001628280-26-061940:0
1,107 shares0Common Stock, $0.10 par valueSEC:0001773367-26-000002:0
1,165 shares0Common Stock, $0.10 par valueSEC:0000014272-25-000072:0
994 shares0Common Stock, $0.10 par valueSEC:0000014272-24-000074:0
616 shares0Common Stock, $0.10 par valueSEC:0000014272-23-000195:0
732 shares@ US$61.14100.0% of flowCommon Stock, $0.10 par valueSEC:0000014272-23-000154:0
6 of 6 declarations
